Bluejay Diagnostics Inc
BJDX
$0.78-1.03%
End of day · as of Oct 16, 2026, 8:01 AM ET
Mkt cap
$4.97M
EV/Sales
-0.80
P/E ratio
N/A
FY2022 Revenue
$249,040
EPS (H1 2026)
$-2.77
Gross Margin (FY2022)
19.64%
Profit Margin (FY2022)
-3733.11%
Beta
0.72
Div yield
N/A
Sector
Healthcare
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Latest reported BJDX revenue for 2022-12-31 was $249.0K. Net income was -$9.3M. BJDX currently screens at market cap $5.0M.
Use this BJDX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BJDX income, balance, and cash tables.
Bluejay Diagnostics Inc (BJDX) is a medical devices company in the Healthcare sector.
Latest cached Bluejay Diagnostics Inc (BJDX) revenue for Dec 31, 2022 was $249.0K. Net income was -$9.3M. Statements: https://lician.com/financials/bjdx
Bluejay Diagnostics Inc (BJDX) market capitalization is $5.0M on the latest cached snapshot.
Bluejay Diagnostics Inc (BJDX) cached previous close $0.79; day range $0.76 – $0.78; volume 87,179. Session quote: https://lician.com/quote/bjdx
Bluejay Diagnostics Inc (BJDX) latest cached earnings event is "BJDX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BJDX filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/bjdx